Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank100
3Y CAGR+37.0%
5Y CAGR+34.2%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
+37.0%/yr
vs -6.5%/yr prior
5Y CAGR
+34.2%/yr
Consistent
Acceleration
+43.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
20252.02+356.0%
20240.44-60.5%
20231.13+42.8%
20220.79+4.4%
20210.75+62.1%
20200.47-32.8%
20190.69-32.7%
20181.03+12.7%
20170.91-4.7%
20160.96-